| Literature DB >> 22682784 |
W Marraoui1, B Jean, M Muheish, S Trouillier, J-L Kemeny, F Dorcier.
Abstract
Among the family of mesenchymatous tumours, inflammatory myofibroblastic tumours (IMT) are an increasingly recognised and defined lesional group due to the great many studies and recent publications. The aetiopathogenicity is still not fully understood. It seems that an immune origin is involved in the pathological process. These masses result from the proliferation of fibroblast and lymphocyte cells associated with collagen wickerwork. Most often benign, they may affect any organ or supporting tissue. However, these lesions remain non-specific and are difficult to distinguish from malignant tumoral processes. Here resides the value of imaging: to make the diagnosis, guide the biopsy and thereby avoid early damaging surgery or an aggressive medical treatment. This is all the more valid since recent papers have shown that corticotherapy of short duration is currently the first intention treatment We here describe the case of a female patient presenting disseminated erythematous lupus who presented a cervical myofibroblastic tumour. The early diagnosis allowed for the initial medical care, which turned out to be effective without resorting to surgery.Entities:
Mesh:
Year: 2012 PMID: 22682784 DOI: 10.1016/j.diii.2012.03.024
Source DB: PubMed Journal: Diagn Interv Imaging ISSN: 2211-5684 Impact factor: 4.026